PYRIDINE DERIVATIVES FOR TREATING PSYCHIATRIC DISORDERS

The present disclosure relates to a compound of the formula; or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, and R6 are as defined herein. It also relates to pharmaceutical compositions comprising a compound of Formula I and to the use of the compound of Formula I for trea...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KRUEGEL, Andrew Carry, O'NEILL, Brian Thomas, COE, Jotham Wadsworth
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present disclosure relates to a compound of the formula; or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, and R6 are as defined herein. It also relates to pharmaceutical compositions comprising a compound of Formula I and to the use of the compound of Formula I for treating psychiatric disorders. La présente invention concerne un composé de formule ; ou un sel pharmaceutiquement acceptable de celui-ci, R1, R2, R3, R4, R5 et R6 étant tels que définis dans la description. L'invention concerne également des compositions pharmaceutiques comprenant un composé de formule I et l'utilisation du composé de formule I pour traiter des troubles psychiatriques.